Report Highlights
The global market for healthcare analytics reached $4.8 billion in 2014. This market is forecasted to grow at a compound annual growth rate (CAGR) of 24.0% to reach nearly $16.9 billion in 2020 from nearly $5.8 billion in 2015.
Report Includes
- An overview of the global markets for healthcare analytics.
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
- A look at how healthcare analytics utilizes systematic data from clinical and business fronts to arrive at insights which are developed with the help of statistical, contextual, quantitative, predictive, and cognitive spectrums.
- Evaluation of factors driving the market such as the introduction of federal healthcare policies, increased focus on data collection and analysis for better customer service, progress in clinical outcomes, rapid technological advances and the emergence of social media.
- Analysis of growth inhibitors such as data security issues, patient data confidentiality, cultural barriers to IT adoption, and lack of manpower with cross-functional analytical skills.
- A look at the role different participants in the industry play including the government, insurers, medical staff, physicians and others.
SCOPE OF REPORT
This research report categorizes the market for healthcare analytics into three types of applications: clinical analytics, business analytics and other analytics.
Clinical analytics is segmented as follows:
- Performance measurement.
- Regulatory reporting.
- Compliance and transparency.
- Provider performance.
- Quality improvement.
- Clinical benchmarking.
- Clinical decision support (CDS).
- Population health management.
- Public health surveillance.
Business analytics is segmented as follows:
- Financial analytics
- Claim analytics.
- Revenue management.
- Risk management analytics.
- Operational analytics.
- Supply chain management.
- Human resources.
- Strategic analytics.
“Other” analytics include:
- Tools used for research results analysis.
- Other analytics function.
The market for healthcare analytics is segmented by end user as follows:
- Payers.
- Government.
- Private.
- Providers.
- Hospitals.
- Medical groups.
- Physician practices.
- Others.
The following geographic markets are analyzed:
- United States.
- Europe.
- Asia.
- Rest of the world (ROW).
The analysis includes the following types of delivery modes:
- On-premises.
- Web-hosted.
- Cloud-based.
Lastly, the market is analyzed by product and segmented as follows:
- Hardware.
- Software.
- Services.
INTENDED AUDIENCE
- Healthcare analytic hardware, software and service providers.
- Healthcare analytics suppliers and distributors.
- Consulting firms.
- R&D companies.
- Physicians and hospitals.
- Government agencies.
- Healthcare agencies.
ANALYST’S CREDENTIALS
Neha Maliwal, a graduate in biotechnology and a postgraduate in marketing and biotechnology at the University of Pune(India), is the author of this study and numerous others, including the analyses of related markets such as antibiotics, radiopharmaceuticals, radiotherapy, healthcare business process outsourcing (BPO) and biotechnology instrumentation.
Related Reports
Healthcare Information Technology
The U.S. market for clinical healthcare information technologies reached $14.1 billion and nearly $15.6 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 4.8% to reach $19.7 billion in 2019.
Global Markets for Telemedicine Technologies
The global telehospital/clinic and telehome market reached $16.3 billion in 2013 and $19.2 billion in 2014, and should reach about $43.4 billion in 2019 with a compound annual growth (CAGR) of 17.7% through 2019.
Mobile Health (mHealth) Technologies and Global Markets
The global mHealth market reached nearly $1.5 billion in 2012. This market is expected to grow to $2.4 billion in 2013 and $21.5 billion in 2018 with a compound annual growth rate (CAGR) of 54.9% over the five-year period from 2013 to 2018.
Wireless Electronic Health Records: Technologies and Global Markets
The global wireless EHR market is expected to reach $ 11.2 billion in 2013.This market is further expected to grow upto $23.5 billion in 2018 with a compound annual growth rate (CAGR) of 16.1%.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More